1-4 of 4
Mark K Gutniak
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

GLP-1 Tablet in Type 2 Diabetes in Fasting and Postprandial Conditions

Mark K Gutniak, MD, PHD, Hillevi Larsson, MD, Steven W Sanders, PHARMD, Olof Juneskans, PHD, Jens J Holst, MD, PHD, Bo Ahrén, MD, PHD
Journal: Diabetes Care
Diabetes Care 1997;20(12):1874–1879
https://doi.org/10.2337/diacare.20.12.1874
Published: 01 December 1997
View article titled, GLP-1 Tablet in Type 2 Diabetes in Fasting and Postprandial Conditions
Open the PDF for GLP-1 Tablet in Type 2 Diabetes in Fasting and Postprandial Conditions in another window
Journal Articles

Glucagon-Like Peptide I Enhances the Insulinotropic Effect of Glibenclamide in NIDDM Patients and in the Perfused Rat Pancreas

Mark K Gutniak, MD, PHD, Lisa Juntti-Berggren, MD, PHD, Per M Hellström, MD, PHD, Amel Guenifi, MD, Jens J Holst, MD, PHD, Suad Efendic, MD
Journal: Diabetes Care
Diabetes Care 1996;19(8):857–863
https://doi.org/10.2337/diacare.19.8.857
Published: 01 August 1996
View article titled, Glucagon-Like Peptide I Enhances the Insulinotropic Effect of Glibenclamide in NIDDM Patients and in the Perfused Rat Pancreas
Open the PDF for Glucagon-Like Peptide I Enhances the Insulinotropic Effect of Glibenclamide in NIDDM Patients and in the Perfused Rat Pancreas in another window
Journal Articles

Potential Therapeutic Levels of Glucagon-Like Peptide I Achieved in Humans by a Buccal Tablet

Mark K Gutniak, MD, PHD, Hillevi Larsson, MD, Sonia J Heiber, BSC, Olof T Juneskans, PHD, Jens J Holst, MD, PHD, Bo Ahrén, MD, PHD
Journal: Diabetes Care
Diabetes Care 1996;19(8):843–848
https://doi.org/10.2337/diacare.19.8.843
Published: 01 August 1996
View article titled, Potential Therapeutic Levels of Glucagon-Like Peptide I Achieved in Humans by a Buccal Tablet
Open the PDF for Potential Therapeutic Levels of Glucagon-Like Peptide I Achieved in Humans by a Buccal Tablet in another window
Journal Articles

Subcutaneous Injection of the Incretin Hormone Glucagon-Like Peptide 1 Abolishes Postprandial Glycemia in NIDDM

Mark K Gutniak, MD, PHD, Birgitta Linde, MD, PHD, Jens J Holst, MD, PHD, Suad Efendić, MD, PHD
Journal: Diabetes Care
Diabetes Care 1994;17(9):1039–1044
https://doi.org/10.2337/diacare.17.9.1039
Published: 01 September 1994
View article titled, Subcutaneous Injection of the Incretin Hormone Glucagon-Like Peptide 1 Abolishes Postprandial Glycemia in NIDDM
Open the PDF for Subcutaneous Injection of the Incretin Hormone Glucagon-Like Peptide 1 Abolishes Postprandial Glycemia in NIDDM in another window